Abstract
To prevent earlier AD, the olfactory test could be used as a
non-invasive and non-expensive tool. To do so we propose to bring
together professional of the recommendations and use them to create a
specific tool. The aging of the population is associated with an increase in people
with #Alzheimer's disease (AD) which causes the cost of care in this
population to be more expensive. To rise the opportunity to prevent or
delay the AD, markers of early detection are essential. All studies are
unanimous and validate the identification of odors as a #biomarker of the
#preclinic stage in AD [1-2]. #Olfactive disease is a precursor to the
transformation of mild cognitive impairment to AD [3] and is as
sensitive as other biological biomarkers [4]. In practice there are
still very few practitioners who use olfactory test on early stage. In
clinical research the literature reviews point to a high variability in
the tools used: either by their connotation too culturally marked, or
because the choice of odors can de discuss, or the specificity of the
tool is too low [5]. There is a real lack of consensus that is
detrimental to the common use. To improved public health and reduce the
overall cost of this disease and allow early detection, it is necessary
to act as soon as possible to react before
For more articles on BJSTR Journal please click on https://biomedres.us/
For more Medical Informatics Articles on BJSTR
Olfactory Test Contributions in the Diagnosis and Follow-Up of MCI and MA Patients by Auriane Gros in BJSTR
follow on Tumblr : https://biomedres.tumblr.com/
follow on Pinetrest : https://www.pinterest.com/biomedres/
follow on Twitter : https://twitter.com/Biomedres01
follow on Pinetrest : https://www.pinterest.com/biomedres/
follow on Twitter : https://twitter.com/Biomedres01
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.